Nanology labs has designed and is developing a novel pharmaceutical agent for cancer detection and therapy. Nanology Labs' product, Manganescan, is safer and more precise than the commercially available agents. It can accurately detects early stage tumors and tumor margin using MRI. It simultaneously can generate oxygen in the tumor to sensitize cancer cells to irradiation and significantly improve radiation therapy outcome.

Nanology Labs Logo



Event details

Date: June 8 - 12, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


34 in total